You don't have permission to access "http://www.medpagetoday.com/podcasts/healthwatch/117795" on this server. Reference #18.4ad7ce17.1759611708.64ecccb6 https://errors.edgesuite.net/18.4ad7ce17.1759611708.64ecccb6
recent report provides encouraging results for a vaccine candidate under development in Russia, but there are still no data showing that any vaccine can prevent COVID-19. It could be months, if not years, before a vaccine reaches the general population.In the meantime, however, scientists are busy looking for an effective treatment to mitigate symptoms or,…
A massive antibody study in England has found that 3.4 million people, or 6 percent of the country’s population, have contracted the coronavirus.The study of over 100,000 volunteers, which the government billed as the largest survey of its kind, indicated the seriousness of the outbreak varied among demographics and different areas across the country.London, with…
With a coronavirus vaccine still months off, companies are rushing to test what may be the next best thing: drugs that deliver antibodies to fight the virus right away, without having to train the immune system to make them.Antibodies are proteins the body makes when an infection occurs; they attach to a virus and help…
Share on PinterestScientists in Canada hope that their new approach could aid in the fight against COVID-19.In January 2020, the couple traveled to Toronto, Canada, and developed what were among the earliest confirmed cases of COVID-19 in North America.It can take years to isolate and develop antibodies as treatments, but a team led by scientists…
Overwhelmed by the demands of caregiving, Quette dialed 911 when she found her teenage son downstairs in their kitchen struggling to breathe. He had rolled his wheelchair to the oven to keep himself warm as he tried to regulate his temperature, she recalled, and was drenched in sweat from an apparent infection. In that moment
KFF Health News chief Washington correspondent Julie Rovner discussed federal policy on vaccine research, vaping, and drug access on Science Friday on May 8. Rovner also discussed the Supreme Court decision on the abortion pill mifepristone on NPR’s Morning Edition on May 5. Click here to hear Rovner on Science Friday. Click here to hear
Here in Washington, we’ve been hearing about tensions between the White House and one of its most controversial — but, at least in some circles, most popular — figures: Robert F. Kennedy Jr. Polling of likely voters indicates that the Health and Human Services secretary can be an asset to Republicans when he’s talking about improving the nation’s food supply or labeling ultraprocessed foods. But when he’s talking about removing recommendations for routine childhood vaccinations, he can be a detriment. So, when I